Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: Incidence and survival in the United States, 1992-2004

British Journal of Haematology

Volumn 144, Issue 1, 2009, Pages 86-94

  Dores, Graça M ^a,b   Landgren, Ola ^b   McGlynn, Katherine A ^b   Curtis, Rochelle E ^b   Linet, Martha S ^b   Devesa, Susan S ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Epidemiology; Lymphoid malignancies; Lymphoproliferative disease; Myeloma; Plasmacytoma

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASIAN; BONE CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER REGISTRY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; EUROPEAN AMERICAN; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; OVERALL SURVIVAL; PLASMA CELL; PLASMACYTOMA; PRIORITY JOURNAL; RACE DIFFERENCE; SURVIVAL TIME; UNITED STATES;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CONFIDENCE INTERVALS; ETHNIC GROUPS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MULTIPLE MYELOMA; NEOPLASMS, PLASMA CELL; PHARYNGEAL NEOPLASMS; PLASMACYTOMA; RESPIRATORY TRACT NEOPLASMS; SEX DISTRIBUTION; SURVIVAL RATE; UNITED STATES;

EID: 57449098438     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07421.x     Document Type: Article

References (42)

1. Alexiou, C., Kau, R.J., Dietzfelbinger, H., Kremer, M., Spiess, J.C., Schratzenstaller, B. Arnold, W. (1999) Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer, 85, 2305 2314.
2. Bataille, R. Sany, J. (1981) Solitary myeloma: clinical and prognostic features of a review of 114 cases. Cancer, 48, 845 851.
3. Bink, K., Haralambieva, E., Kremer, M., Ott, G., Beham-Schmid, C., de Leval, L., Peh, S.C., Laeng, H.R., Jutting, U., Hutzler, P., Quintanilla-Martinez, L. Fend, F. (2008) Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics. Haematologica, 93, 623 626.
4. Bolek, T.W., Marcus, R.B. Mendenhall, N.P. (1996) Solitary plasmacytoma of bone and soft tissue. International Journal of Radiation Oncology, Biology, Physics, 36, 329 333.
5. Brenner, H., Gondos, A. Pulte, D. (2008) Recent major improvement in long-term survival of younger patients with multiple myeloma. Blood, 111, 2521 2526.
6. Brinch, L., Hannisdal, E., Abrahamsen, A.F., Kvaloy, S. Langholm, R. (1990) Extramedullary plasmacytomas and solitary plasma cell tumours of bone. European Journal of Haematology, 44, 132 135.
7. Brown, C.C. (1983) The statistical comparison of relative survival rates. Biometrics, 39, 941 948.
8. Chak, L.Y., Cox, R.S., Bostwick, D.G. Hoppe, R.T. (1987) Solitary plasmacytoma of bone: treatment, progression, and survival. Journal of Clinical Oncology, 5, 1811 1815.
9. Chao, M.W., Gibbs, P., Wirth, A., Quong, G., Guiney, M.J. Liew, K.H. (2005) Radiotherapy in the management of solitary extramedullary plasmacytoma. Internal Medicine Journal, 35, 211 215.
10. Devesa, S.S., Donaldson, J. Fears, T. (1995) Graphical presentation of trends in rates. American Journal of Epidemiology, 141, 300 304.
11. Dimopoulos, M.A., Moulopoulos, L.A., Maniatis, A. Alexanian, R. (2000) Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Blood, 96, 2037 2044.
12. Dingli, D., Kyle, R.A., Rajkumar, S.V., Nowakowski, G.S., Larson, D.R., Bida, J.P., Gertz, M.A., Therneau, T.M., Melton, III., L.J., Dispenzieri, A. Katzmann, J.A. (2006) Immunoglobulin free light chains and solitary plasmacytoma of bone. Blood, 108, 1979 1983.
13. Frassica, D.A., Frassica, F.J., Schray, M.F., Sim, F.H. Kyle, R.A. (1989) Solitary plasmacytoma of bone: Mayo Clinic experience. International Journal of Radiation Oncology, Biology, Physics, 16, 43 48.
14. Fritz, A., Percy, C., Jack, A., Shanmugaratnam, K., Sobin, L., Parkin, D.M. Whelan, S. (eds 2000) International Classification of Diseases for Oncology. World Health Organization, Geneva (Switzerland).
15. Galieni, P., Cavo, M., Avvisati, G., Pulsoni, A., Falbo, R., Bonelli, M.A., Russo, D., Petrucci, M.T., Bucalossi, A. Tura, S. (1995) Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different entities? Annals of Oncology, 6, 687 691.
16. Galieni, P., Cavo, M., Pulsoni, A., Avvisati, G., Bigazzi, C., Neri, S., Caliceti, U., Benni, M., Ronconi, S. Lauria, F. (2000) Clinical outcome of extramedullary plasmacytoma. Haematologica, 85, 47 51.
17. Gebregziabher, M., Bernstein, L., Wang, Y. Cozen, W. (2006) Risk patterns of multiple myeloma in Los Angeles County, 1972-1999 (United States). Cancer Causes and Control, 17, 931 938.
18. Holland, J., Trenkner, D.A., Wasserman, T.H. Fineberg, B. (1992) Plasmacytoma. Treatment results and conversion to myeloma. Cancer, 69, 1513 1517.
19. International Myeloma Working Group 2003) Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. British Journal Haematology, 121, 749 757.
20. Jackson, A. Scarffe, J.H. (1990) Prognostic significance of osteopenia and immunoparesis at presentation in patients with solitary myeloma of bone. European Journal of Cancer, 26, 363 371.
21. Jaffe, E.S., Harris, N.L., Stein, H. Vardiman, J.W. (eds 2001) World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon.
22. Knobel, D., Zouhair, A., Tsang, R.W., Poortmans, P., Belkacemi, Y., Bolla, M., Oner, F.D., Landmann, C., Castelain, B. Ozsahin, M. (2006) Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study. BMC Cancer, 6, 118.
23. Knowling, M.A., Harwood, A.R. Bergsagel, D.E. (1983) Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone. Journal of Clinical Oncology, 1, 255 262.
24. Kristinsson, S.Y., Landgren, O., Dickman, P.W., Derolf, A.R. Bjorkholm, M. (2007) Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003. Journal of Clinical Oncology, 25, 1993 1999.
25. Kumar, S.K., Rajkumar, S.V., Dispenzieri, A., Lacy, M.Q., Hayman, S.R., Buadi, F.K., Zeldenrust, S.R., Dingli, D., Russell, S.J., Lust, J.A., Greipp, P.R., Kyle, R.A. Gertz, M.A. (2008) Improved survival in multiple myeloma and the impact of novel therapies. Blood, 111, 2516 2520.
26. Kyle, R.A. (1992) Diagnostic criteria of multiple myeloma. Hematology/Oncology Clinics of North America, 6, 347 358.
27. Landgren, O., Gridley, G., Turesson, I., Caporaso, N.E., Goldin, L.R., Baris, D., Fears, T.R., Hoover, R.N. Linet, M.S. (2006) Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood, 107, 904 906.
28. Landgren, O., Katzmann, J.A., Hsing, A.W., Pfeiffer, R.M., Kyle, R.A., Yeboah, E.D., Biritwum, R.B., Tettey, Y., Adjei, A.A., Larson, D.R., Dispenzieri, A., Melton, III., L.J., Goldin, L.R., McMaster, M.L., Caporaso, N.E. Rajkumar, S.V. (2007) Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana. Mayo Clinic Proceedings, 82, 1468 1473.
29. Liebross, R.H., Ha, C.S., Cox, J.D., Weber, D., Delasalle, K. Alexanian, R. (1998) Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 41, 1063 1067.
30. Liebross, R.H., Ha, C.S., Cox, J.D., Weber, D., Delasalle, K. Alexanian, R. (1999) Clinical course of solitary extramedullary plasmacytoma. Radiotherapy and Oncology, 52, 245 249.
31. Linet, M.S., Devesa, S.S. Morgan, G.J. (2005) New perspectives on the epidemiology of hematological malignancies and related disorders. In : Cancer Risk Assessment (ed. by P.G. Shields pp. 671 716. Taylor and Francis, New York.
32. Ludwig, H., Durie, B.G., Bolejack, V., Turesson, I., Kyle, R.A., Blade, J., Fonseca, R., Dimopoulos, M., Shimizu, K., San Miguel, J., Westin, J., Harousseau, J.L., Beksac, M., Boccadoro, M., Palumbo, A., Barlogie, B., Shustik, C., Cavo, M., Joshua, D., Attal, M., Sonneveld, P. Crowley, J. (2008) Myeloma in patients under age 50 presents with more favorable features and shows better survival: an analysis of 10,549 patients from the International Myeloma Working Group. Blood, 111, 4039 4047.
33. Morton, L.M., Wang, S.S., Devesa, S.S., Hartge, P., Weisenburger, D.D. Linet, M.S. (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood, 107, 265 276.
34. Ozsahin, M., Tsang, R.W., Poortmans, P., Belkacemi, Y., Bolla, M., Dincbas, F.O., Landmann, C., Castelain, B., Buijsen, J., Curschmann, J., Kadish, S.P., Kowalczyk, A., Anacak, Y., Hammer, J., Nguyen, T.D., Studer, G., Cooper, R., Sengoz, M., Scandolaro, L. Zouhair, A. (2006) Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patients. International Journal of Radiation Oncology, Biology, Physics, 64, 210 217.
35. Pahor, A.L. (1977) Extramedullary plasmacytoma of the head and neck, parotid and submandibular salivary glands. Journal of Laryngology and Otology, 91, 241 258.
36. Percy, C., Van Holten, V. Muir, C. (eds 1990) International Classification of Diseases for Oncology. World Health Organization, Geneva, Switzerland.
37. Ries, L.A.G., Young, Jr., J.L., Keel, G.E., Eisner, M.P., Lin, Y.D. Horner, M.-J. (2007) SEER Survival Monograph: Cancer Survival Among Adults: US. SEER Program, 1988-2001, Patient and Tumor Characteristics. National Cancer Institute, SEER Program.
38. SEER-12 (2007) Surveillance, Epidemiology, and End Results (SEER) Program (http://www.seer.cancer.gov). SEER*Stat Database: Incidence - SEER 12 Regs Limited-Use, Nov 2006 Sub (1992-2004) - Linked To County Attributes - Total US, 1969-2004 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2007, based on the November 2006 submission.
39. Shih, L.Y., Dunn, P., Leung, W.M., Chen, W.J. Wang, P.N. (1995) Localised plasmacytomas in Taiwan: comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone. British Journal of Cancer, 71, 128 133.
40. Soutar, R., Lucraft, H., Jackson, G., Reece, A., Bird, J., Low, E. Samson, D. (2004) Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. British Journal Haematology, 124, 717 726.
41. Strojan, P., Soba, E., Lamovec, J. Munda, A. (2002) Extramedullary plasmacytoma: clinical and histopathologic study. International Journal of Radiation Oncology, Biology, Physics, 53, 692 701.
42. Wiltshaw, E. (1976) The natural history of extramedullary plasmacytoma and its relation to solitary myeloma of bone and myelomatosis. Medicine (Baltimore), 55, 217 238.